Linear IgA bullous dermatosis treated with rituximab
暂无分享,去创建一个
L. Sacré | V. Hébert | P. Joly | M. Lecuyer | C. Pinard | Laurine Sacré
[1] J. Zone,et al. Rituximab Treatment for Recalcitrant Dermatitis Herpetiformis , 2017, JAMA dermatology.
[2] M. Shimoda,et al. Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab. , 2015, JAMA dermatology.
[3] L. Sagi,et al. [Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders]. , 2012, Harefuah.
[4] R. Vodegel,et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. , 2002, Journal of the American Academy of Dermatology.
[5] J. Roujeau,et al. Drug‐induced linear IgA disease: target antigens are heterogeneous , 1997, The British journal of dermatology.
[6] L. Vaillant,et al. Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions , 1995 .